ES518582A0 - Un procedimiento para preparar una composicion farmaceutica acuosa que contiene ubidecarenona. - Google Patents
Un procedimiento para preparar una composicion farmaceutica acuosa que contiene ubidecarenona.Info
- Publication number
- ES518582A0 ES518582A0 ES518582A ES518582A ES518582A0 ES 518582 A0 ES518582 A0 ES 518582A0 ES 518582 A ES518582 A ES 518582A ES 518582 A ES518582 A ES 518582A ES 518582 A0 ES518582 A0 ES 518582A0
- Authority
- ES
- Spain
- Prior art keywords
- preparing
- procedure
- pharmaceutical composition
- composition containing
- aqueous pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56209972A JPS58113127A (ja) | 1981-12-28 | 1981-12-28 | ユビデカレノン含有水性液 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES518582A0 true ES518582A0 (es) | 1984-02-01 |
ES8402503A1 ES8402503A1 (es) | 1984-02-01 |
Family
ID=16581723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES518582A Expired ES8402503A1 (es) | 1981-12-28 | 1982-12-27 | Un procedimiento para preparar una composicion farmaceutica acuosa que contiene ubidecarenona. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4483873A (es) |
EP (1) | EP0083108B1 (es) |
JP (1) | JPS58113127A (es) |
KR (1) | KR880002410B1 (es) |
AT (1) | ATE22006T1 (es) |
CA (1) | CA1176568A (es) |
DE (1) | DE3273257D1 (es) |
ES (1) | ES8402503A1 (es) |
NO (1) | NO156553C (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1157269B (it) * | 1982-03-19 | 1987-02-11 | Seuref Ag | Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica |
JPS5910511A (ja) * | 1982-07-07 | 1984-01-20 | Eisai Co Ltd | 脂溶性物質含有水性液 |
JPS6025918A (ja) * | 1983-07-25 | 1985-02-08 | Ajinomoto Co Inc | 脂溶性薬物含有水性液 |
CH661438A5 (it) * | 1984-04-09 | 1987-07-31 | Seuref Ag | Composizioni farmaceutiche ad azione antianossica e metabolica cerebrale. |
IT1191608B (it) * | 1985-02-01 | 1988-03-23 | Zambon Spa | Composizione farmaceutica e forme farmaceutiche che la contengono |
US4824669A (en) * | 1985-04-11 | 1989-04-25 | Board Of Regents, The University Of Texas System | Formulations of coenzyme Q10 for intravenous use |
DE3524788A1 (de) * | 1985-07-11 | 1987-01-22 | Lentia Gmbh | Stabile, intravenoes applizierbare, waessrige fettemulsion und ein verfahren zu deren herstellung |
CH667387A5 (it) * | 1985-12-24 | 1988-10-14 | Seuref Ag | Formulazioni farmaceutiche acquose di ubichinone. |
US4911929A (en) * | 1986-08-29 | 1990-03-27 | The United States Of America As Represented By The Secretary Of The Navy | Blood substitute comprising liposome-encapsulated hemoglobin |
US5154930A (en) * | 1987-03-05 | 1992-10-13 | The Liposome Company, Inc. | Pharmacological agent-lipid solution preparation |
CA1323306C (en) * | 1987-03-05 | 1993-10-19 | Mircea C. Popescu | Pharmacological agent-lipid solution preparation |
IT1250672B (it) * | 1991-07-11 | 1995-04-21 | Idb Holding Spa | Formulazioni orali di ubidecarenone in soluzione acquosa |
ES2051643B1 (es) * | 1992-10-13 | 1995-02-16 | Inverni Della Beffa Farma | Formulaciones orales de ubidecarenona en forma de soluciones acuosas. |
GR1001364B (el) * | 1992-10-16 | 1993-10-29 | Inverni Della Beffa Farma | Από του στόματος συν?έσεις ουβιδεκαρενόνης υπό μορφήν υδατικών διαλυμάτων. |
JP3106820B2 (ja) * | 1993-12-08 | 2000-11-06 | アールティーエー・アソシエーツ有限会社 | 畜肉、魚肉およびこれらの加工品の鮮度保持剤並びに生産性改善剤 |
DE4405545A1 (de) * | 1994-02-22 | 1995-08-31 | Dietl Hans | Fettlösliche Vitamine enthaltende Zubereitung zur oralen Applikation |
US6403116B1 (en) | 2000-11-03 | 2002-06-11 | Triarco Inductries, Inc. | Coenzyme Q10 formulation |
US6300377B1 (en) * | 2001-02-22 | 2001-10-09 | Raj K. Chopra | Coenzyme Q products exhibiting high dissolution qualities |
US20050260752A1 (en) * | 2003-04-01 | 2005-11-24 | Wilding Martin G | Culture medium containing enhancers of oxidative phosphorylation |
US7438903B2 (en) * | 2003-06-06 | 2008-10-21 | Nbty, Inc. | Methods and compositions that enhance bioavailability of coenzyme-Q10 |
CN102258503B (zh) | 2004-01-22 | 2019-08-16 | 迈阿密大学 | 局部辅酶q10制剂及其使用方法 |
US7803366B2 (en) * | 2004-05-07 | 2010-09-28 | Nbty, Inc. | Methods and compositions that enhance bioavailability of coenzyme-Q10 |
JP6058263B2 (ja) | 2008-04-11 | 2017-01-11 | バーグ リミテッド ライアビリティ カンパニー | 癌細胞においてアポトーシスを誘導する方法および使用 |
US20110144376A1 (en) * | 2008-08-20 | 2011-06-16 | Showa Denko K.K. | Dermatological agent |
US9005608B2 (en) * | 2009-03-24 | 2015-04-14 | Adds Pharmaceuticals Llc | Stabilized solubility-enhanced formulations for oral delivery |
US20110020312A1 (en) | 2009-05-11 | 2011-01-27 | Niven Rajin Narain | Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
CN103608323B (zh) | 2011-04-04 | 2016-08-17 | 博格有限责任公司 | 治疗中枢神经***肿瘤的方法 |
AU2014251045B2 (en) | 2013-04-08 | 2019-06-13 | Berg Llc | Treatment of cancer using coenzyme Q10 combination therapies |
SG11201601583TA (en) | 2013-09-04 | 2016-04-28 | Berg Llc | Methods of treatment of cancer by continuous infusion of coenzyme q10 |
EP3476388B1 (en) | 2017-10-24 | 2021-09-29 | Difass International S.p.A. | Composition comprising coenzyme q10 and piperine |
EP4101442A1 (en) * | 2021-06-11 | 2022-12-14 | Tradichem Industrial Services, S.L. | Process for preparing compacted coenzyme q10 particles of high density and improved flowability |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5283911A (en) * | 1976-01-01 | 1977-07-13 | Ajinomoto Co Inc | Fat emulsion for intravenous injection |
JPS5845403B2 (ja) * | 1976-02-14 | 1983-10-08 | エーザイ株式会社 | 補酵素qを主成分とする膵機能亢進剤 |
JPS5356315A (en) * | 1976-11-01 | 1978-05-22 | Eisai Co Ltd | Emulsified solution of fat soluble drugs |
JPS5562010A (en) * | 1978-10-31 | 1980-05-10 | Ajinomoto Co Inc | Fat emulsion for intravenous injection |
JPS5618914A (en) * | 1979-07-25 | 1981-02-23 | Eisai Co Ltd | Ubidecarenone composition having good absorbability |
FR2471384A1 (fr) * | 1979-12-11 | 1981-06-19 | Richter Gedeon Vegyeszet | Procede de preparation de tartrate d'ergotamine |
FR2472384A1 (fr) * | 1979-12-27 | 1981-07-03 | Sederma Sa | Utilisation en cosmetologie de complexes naturels constitues d'ubiquinones et de phospholipides |
JPS5775916A (en) * | 1980-10-29 | 1982-05-12 | Nippon Chemiphar Co Ltd | Coenzyme q pharmaceutical and its preparation |
-
1981
- 1981-12-28 JP JP56209972A patent/JPS58113127A/ja active Granted
-
1982
- 1982-12-23 US US06/452,844 patent/US4483873A/en not_active Expired - Fee Related
- 1982-12-23 CA CA000418509A patent/CA1176568A/en not_active Expired
- 1982-12-27 NO NO824380A patent/NO156553C/no unknown
- 1982-12-27 ES ES518582A patent/ES8402503A1/es not_active Expired
- 1982-12-28 EP EP82112068A patent/EP0083108B1/en not_active Expired
- 1982-12-28 DE DE8282112068T patent/DE3273257D1/de not_active Expired
- 1982-12-28 KR KR8205848A patent/KR880002410B1/ko active
- 1982-12-28 AT AT82112068T patent/ATE22006T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS58113127A (ja) | 1983-07-05 |
CA1176568A (en) | 1984-10-23 |
EP0083108A3 (en) | 1983-12-14 |
JPH0322363B2 (es) | 1991-03-26 |
KR880002410B1 (ko) | 1988-11-08 |
NO156553C (no) | 1987-10-14 |
DE3273257D1 (en) | 1986-10-16 |
EP0083108B1 (en) | 1986-09-10 |
NO824380L (no) | 1983-06-29 |
NO156553B (no) | 1987-07-06 |
ES8402503A1 (es) | 1984-02-01 |
ATE22006T1 (de) | 1986-09-15 |
KR840002650A (ko) | 1984-07-16 |
EP0083108A2 (en) | 1983-07-06 |
US4483873A (en) | 1984-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES518582A0 (es) | Un procedimiento para preparar una composicion farmaceutica acuosa que contiene ubidecarenona. | |
ES500916A0 (es) | Un procedimiento para la preparacion y estabilizacion de una composicion blanqueante acuosa que contiene peroxido de hi-drogeno. | |
ES513372A0 (es) | Procedimiento para la obtencion de composiciones de lejia liquida de solucion de hipoclorito. | |
ES511515A0 (es) | Procedimiento para la preparacion de polvos conteniendo alcohol. | |
ES503790A0 (es) | Un procedimiento para la preparacion de una composicion de derivados del imidazor. | |
MX7536E (es) | Procedimiento para preparar caramelo macizo que contiene sorbitol | |
ES502402A0 (es) | Un procedimiento para la preparacion de nuevos derivados de ariletanolamina. | |
ES504046A0 (es) | Un procedimiento para preparar una composicion farmaceutica que contiene 9-(2-hidroxietoximetil)guanina. | |
ES515443A0 (es) | Procedimiento para la preparacion de productos para la proteccion contra la polilla. | |
MX9304793A (es) | Glicanas de actividad inmunoestimulante. | |
ES2054746T3 (es) | Aditivo para piensos estabilizado y procedimiento para su preparacion. | |
JPS5294433A (en) | Perfume blender | |
ES513789A0 (es) | "un procedimiento para preparar un liposoma que contiene ubidecarenona". | |
ES517296A0 (es) | Un procedimiento para la preparacion de nuevos derivados de propanolamina. | |
IT8206957V0 (it) | Dispositivo per il collegamento rapido di due alberi. | |
IE822519L (en) | Phosphonic acid derivatives | |
IT8224053A0 (it) | Procedimento per la preparazione di derivati di eburnamonina. | |
ES517295A0 (es) | Un procedimiento para la preparacion de nuevos derivados de propanolamina. | |
ES2084878T3 (es) | Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. | |
MX3897E (es) | Un procedimiento para la preparacion de composiciones insecticidas que contienen (6,7,8,9,10,10-hexacloro-1,5,5a,6,9,9a,-hexahidro-6,9-metano-2,4,3,-benzodioxatiepin-3-oxido) | |
ES507277A0 (es) | Procedimiento para preparar derivados de sulfonilurea de efecto antidoto contra herbicidas del tipo tiolcarbamato. | |
ES498016A0 (es) | Procedimiento para la produccion de compuestos que contienen clorotriacinilo. | |
ES511577A0 (es) | Procedimiento para la preparacion del heteropolisacarido s-198. | |
IT1210473B (it) | Procedimento per la preparazione di derivati ergolinici. | |
IT8002918A0 (it) | Procedimento per la stabilizzazione di vitamine. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20010402 |